[go: up one dir, main page]

MX2017000609A - Dispositivo y metodo de entrega de implante ocular. - Google Patents

Dispositivo y metodo de entrega de implante ocular.

Info

Publication number
MX2017000609A
MX2017000609A MX2017000609A MX2017000609A MX2017000609A MX 2017000609 A MX2017000609 A MX 2017000609A MX 2017000609 A MX2017000609 A MX 2017000609A MX 2017000609 A MX2017000609 A MX 2017000609A MX 2017000609 A MX2017000609 A MX 2017000609A
Authority
MX
Mexico
Prior art keywords
frame
implant
central channel
distal end
eye
Prior art date
Application number
MX2017000609A
Other languages
English (en)
Other versions
MX384889B (es
Inventor
Sponsel Mark
Vedrine Lionel
Waitz Ariel
BIANCHI Keith
HARTSIG Bill
Nunn Scott
Patel Mukund
Original Assignee
Forsight Vision4 Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forsight Vision4 Inc filed Critical Forsight Vision4 Inc
Publication of MX2017000609A publication Critical patent/MX2017000609A/es
Publication of MX384889B publication Critical patent/MX384889B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0017—Introducing ophthalmic products into the ocular cavity or retaining products therein implantable in, or in contact with, the eye, e.g. ocular inserts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/0008—Introducing ophthalmic products into the ocular cavity or retaining products therein
    • A61F9/0026—Ophthalmic product dispenser attachments to facilitate positioning near the eye
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F9/00—Methods or devices for treatment of the eyes; Devices for putting in contact-lenses; Devices to correct squinting; Apparatus to guide the blind; Protective devices for the eyes, carried on the body or in the hand
    • A61F9/007—Methods or devices for eye surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A61K9/0051—Ocular inserts, ocular implants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body

Landscapes

  • Health & Medical Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Surgery (AREA)
  • Anesthesiology (AREA)
  • Hematology (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Prostheses (AREA)

Abstract

Un sistema de implante ocular que incluye un implante ocular dimensionado y formado para ser insertado al menos parcialmente en un ojo; un miembro portador con un armazón, cubierta o envoltura que tiene un canal central que se extiende al menos parcialmente a través del armazón desde un extremo proximal hacia un extremo distal del armazón. Un manguito guía fijado de forma desmontable dentro de al menos una primera región del canal central del armazón y definiendo un puerto proximal dentro del canal central que es accesible desde el extremo proximal del armazón. Un soporte de implante fijado de forma desmontable dentro de al menos una segunda región del canal central del armazón adyacente a un extremo distal del manguito guía y teniendo un par de agarres adaptados para asegurar de forma liberable el implante en un extremo distal del soporte de implante. Se describen dispositivos, sistemas y / o métodos relacionados.
MX2017000609A 2014-07-15 2015-07-15 Dispositivo y metodo de entrega de implante ocular. MX384889B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462024682P 2014-07-15 2014-07-15
PCT/US2015/040633 WO2016011191A1 (en) 2014-07-15 2015-07-15 Ocular implant delivery device and method

Publications (2)

Publication Number Publication Date
MX2017000609A true MX2017000609A (es) 2017-04-27
MX384889B MX384889B (es) 2025-03-14

Family

ID=55079028

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017000609A MX384889B (es) 2014-07-15 2015-07-15 Dispositivo y metodo de entrega de implante ocular.

Country Status (15)

Country Link
US (4) US10258503B2 (es)
EP (2) EP3169289B1 (es)
JP (1) JP6581194B2 (es)
KR (1) KR102416726B1 (es)
CN (1) CN106687079B (es)
AU (1) AU2015289625B2 (es)
BR (1) BR112017000774B1 (es)
CA (1) CA2955186C (es)
ES (2) ES2992100T3 (es)
IL (1) IL250079B (es)
MX (1) MX384889B (es)
MY (1) MY182497A (es)
RU (1) RU2695563C2 (es)
WO (1) WO2016011191A1 (es)
ZA (1) ZA201700387B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG2014007389A (en) 2009-01-29 2014-04-28 Forsight Vision4 Inc Posterior segment drug delivery
WO2013116061A1 (en) 2012-02-03 2013-08-08 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
US9526654B2 (en) 2013-03-28 2016-12-27 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
CA2955186C (en) 2014-07-15 2023-08-29 Forsight Vision4, Inc. Ocular implant delivery device and method
WO2016014996A1 (en) 2014-07-24 2016-01-28 Sinopsys Surgical, Inc. Apparatuses, tools, kits and methods relating to paranasal sinus access
CA2957548A1 (en) 2014-08-08 2016-02-11 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
CN107249515B (zh) 2014-11-10 2019-10-01 弗赛特影像4股份有限公司 可膨胀药物递送装置和使用方法
JP6912475B2 (ja) 2015-11-20 2021-08-04 フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． 持続放出性薬物送達機器用の多孔質構造体
EP3439591B1 (en) 2016-04-05 2020-09-23 ForSight Vision4, Inc. Implantable ocular drug delivery devices
FI3675780T3 (fi) 2017-09-20 2025-03-13 Sinopsys Surgical Inc Paranasaaliseen sinukseen nestepääsyn mahdollistavia implantointityökaluja ja -kokoonpanoja
CN111655206B (zh) 2017-11-21 2022-10-14 弗赛特影像4股份有限公司 用于可扩展端口递送系统的流体交换装置及使用方法
EP3698758A1 (en) * 2019-02-20 2020-08-26 Leibniz-Institut für Polymerforschung Dresden e.V. Device and assemblies for oriented transport, microscopic investigation and oriented ejection of a tissue graft or implant
CN110507476B (zh) * 2019-09-12 2021-10-26 格劳科斯公司 制造眼部植入物输送装置的方法
CN115209835A (zh) * 2020-02-27 2022-10-18 伊斯塔尔医疗公司 用于保持和分配用于输送植入物的输送轴组件的包装件
PL4114305T3 (pl) * 2020-02-27 2024-07-01 Istar Medical Sa Opakowanie do przechowywania i wydawania zespołu wału dostarczającego do dostarczania implantu
US20220054311A1 (en) * 2020-08-12 2022-02-24 United States Government As Represented By The Department Of Veterans Affairs Eye Drop Dispensing Apparatus
US12268633B2 (en) 2020-11-04 2025-04-08 Alcon Inc. Medical implant
KR20240058194A (ko) 2021-09-20 2024-05-03 모트 코포레이션 의료 장치용 중합체 코팅 및 제조 방법
USD1037439S1 (en) 2022-01-17 2024-07-30 EyePoint Pharamaceuticals, Inc. Ocular injector
USD1033637S1 (en) 2022-01-24 2024-07-02 Forsight Vision4, Inc. Fluid exchange device
CN114848289B (zh) * 2022-05-06 2025-02-14 海思盖德(苏州)生物医学科技有限公司 一种眼部植入物输送器
CN114983670B (zh) * 2022-05-30 2025-08-01 海思盖德(苏州)生物医学科技有限公司 一种眼内植入物输送器
USD1101145S1 (en) 2022-08-11 2025-11-04 Genentech, Inc. Ocular incision guide tool
CN118512302B (zh) * 2024-07-23 2024-10-01 苏州朗目医疗科技有限公司 一种眼用缓释药输送系统

Family Cites Families (369)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2585815A (en) 1947-01-16 1952-02-12 Mclintock Duncan Menzies Injection syringe
US2564977A (en) 1949-01-19 1951-08-21 Hu Quang Hsi Medical injecting apparatus
US3232117A (en) 1962-09-14 1966-02-01 Roger Gilmont Instr Inc Micrometer buret
US3416530A (en) 1966-03-02 1968-12-17 Richard A. Ness Eyeball medication dispensing tablet
US3538916A (en) * 1968-12-19 1970-11-10 Joseph S Wiles Injection pistol
US3618604A (en) 1969-06-09 1971-11-09 Alza Corp Ocular insert
US3641237A (en) 1970-09-30 1972-02-08 Nat Patent Dev Corp Zero order release constant elution rate drug dosage
US4034756A (en) 1971-01-13 1977-07-12 Alza Corporation Osmotically driven fluid dispenser
US3995635A (en) 1971-09-09 1976-12-07 Alza Corporation Ocular insert
US3828777A (en) 1971-11-08 1974-08-13 Alza Corp Microporous ocular device
US3916899A (en) 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3902495A (en) 1974-01-28 1975-09-02 Cavitron Corp Flow control system
US3961628A (en) 1974-04-10 1976-06-08 Alza Corporation Ocular drug dispensing system
US3949748A (en) 1974-09-26 1976-04-13 Oscar Malmin Injection syringe having aspirating and metering capabilities
US3949750A (en) 1974-10-07 1976-04-13 Freeman Jerre M Punctum plug and method for treating keratoconjunctivitis sicca (dry eye) and other ophthalmic aliments using same
US4135514A (en) 1974-12-23 1979-01-23 Alza Corporation Osmotic releasing system for administering ophthalmic drug to eye of animal
US4014335A (en) 1975-04-21 1977-03-29 Alza Corporation Ocular drug delivery device
US3977404A (en) 1975-09-08 1976-08-31 Alza Corporation Osmotic device having microporous reservoir
US4034758A (en) 1975-09-08 1977-07-12 Alza Corporation Osmotic therapeutic system for administering medicament
US4014333A (en) 1975-09-22 1977-03-29 Mcintyre David J Instrument for aspirating and irrigating during ophthalmic surgery
US4077407A (en) 1975-11-24 1978-03-07 Alza Corporation Osmotic devices having composite walls
US4008719A (en) 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
US4014334A (en) 1976-02-02 1977-03-29 Alza Corporation Laminated osmotic system for dispensing beneficial agent
US4111203A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111201A (en) 1976-11-22 1978-09-05 Alza Corporation Osmotic system for delivering selected beneficial agents having varying degrees of solubility
US4160452A (en) 1977-04-07 1979-07-10 Alza Corporation Osmotic system having laminated wall comprising semipermeable lamina and microporous lamina
US4256108A (en) 1977-04-07 1981-03-17 Alza Corporation Microporous-semipermeable laminated osmotic system
US4220152A (en) 1978-05-08 1980-09-02 Pfizer Inc. Delivery system
US4220153A (en) 1978-05-08 1980-09-02 Pfizer Inc. Controlled release delivery system
US4200098A (en) 1978-10-23 1980-04-29 Alza Corporation Osmotic system with distribution zone for dispensing beneficial agent
US4298000A (en) 1978-11-08 1981-11-03 Minnesota Mining And Manufacturing Company Fluid dispensing device
US4300557A (en) 1980-01-07 1981-11-17 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Method for treating intraocular malignancies
US4309776A (en) 1980-05-13 1982-01-12 Ramon Berguer Intravascular implantation device and method of using the same
US4326525A (en) 1980-10-14 1982-04-27 Alza Corporation Osmotic device that improves delivery properties of agent in situ
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4484922A (en) 1981-06-25 1984-11-27 Rosenwald Peter L Occular device
US4439196A (en) 1982-03-18 1984-03-27 Merck & Co., Inc. Osmotic drug delivery system
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
US4519801A (en) 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4673405A (en) 1983-03-04 1987-06-16 Alza Corporation Osmotic system with instant drug availability
US4883459A (en) 1983-07-29 1989-11-28 Reynaldo Calderon Retrograde perfusion
US4627850A (en) 1983-11-02 1986-12-09 Alza Corporation Osmotic capsule
US4777049A (en) 1983-12-01 1988-10-11 Alza Corporation Constant release system with pulsed release
US4712550A (en) 1985-04-08 1987-12-15 Sinnett Kevin B Retinal tack
US4693886A (en) 1985-04-22 1987-09-15 Alza Corporation Osmotic device with inert core
US4609374A (en) 1985-04-22 1986-09-02 Alza Corporation Osmotic device comprising means for governing initial time of agent release therefrom
EP0201611A1 (de) 1985-05-10 1986-11-20 B. Braun-SSC AG Zwei-Kanülen-Spritze
US4781675A (en) 1985-11-27 1988-11-01 White Thomas C Infusion cannula
EP0228185B1 (en) 1985-11-27 1990-07-25 Thomas C. White Tissue-implantable fluid-dissipating device
US4959217A (en) 1986-05-22 1990-09-25 Syntex (U.S.A.) Inc. Delayed/sustained release of macromolecules
US5322691A (en) 1986-10-02 1994-06-21 Sohrab Darougar Ocular insert with anchoring protrusions
US4863457A (en) 1986-11-24 1989-09-05 Lee David A Drug delivery device
DE3751871T4 (de) 1986-12-23 1998-03-26 Liposome Co Inc Guanidinaminoglycosid enthaltende Liposome
US4865846A (en) 1988-06-03 1989-09-12 Kaufman Herbert E Drug delivery system
US5174999A (en) 1988-12-13 1992-12-29 Alza Corporation Delivery system comprising fluid ingress and drug egress
AU4951690A (en) 1988-12-30 1990-08-01 David M. Anderson Stabilized microporous materials and hydrogel materials
US5098443A (en) 1989-03-23 1992-03-24 University Of Miami Method of implanting intraocular and intraorbital implantable devices for the controlled release of pharmacological agents
US5164188A (en) 1989-11-22 1992-11-17 Visionex, Inc. Biodegradable ocular implants
US5324280A (en) 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
US5128145A (en) 1990-06-13 1992-07-07 Alza Corporation Dosage form for Parkinson's disease, spasticity and muscle spasms
US5084021A (en) 1990-11-02 1992-01-28 Baldwin Brian E Patient controlled infusion apparatus and method
US5378475A (en) 1991-02-21 1995-01-03 University Of Kentucky Research Foundation Sustained release drug delivery devices
AU650113B2 (en) 1991-04-05 1994-06-09 Eli Lilly And Company Sustained release capsule and formulations
US5334189A (en) 1991-06-03 1994-08-02 Wade Stephen E Device for controlled diffusion of a chemical substance
US5282829A (en) 1991-08-15 1994-02-01 United States Surgical Corporation Hollow body implants
FR2682090B1 (fr) 1991-10-03 1993-12-31 Holzstoff Holding Sa Systeme-reservoir pour diffusion prolongee d'un principe actif.
US5681572A (en) 1991-10-18 1997-10-28 Seare, Jr.; William J. Porous material product and process
US5178622A (en) * 1991-11-01 1993-01-12 Lehner Ii Robert H Instrument for implanting a soft intraocular lens
US5178635A (en) 1992-05-04 1993-01-12 Allergan, Inc. Method for determining amount of medication in an implantable device
US6096756A (en) 1992-09-21 2000-08-01 Albert Einstein College Of Medicine Of Yeshiva University Method of simultaneously enhancing analgesic potency and attenuating dependence liability caused by morphine and other bimodally-acting opioid agonists
US5336175A (en) 1992-10-29 1994-08-09 Mames Robert N Method for the treatment of retinal detachments
US5443505A (en) 1993-11-15 1995-08-22 Oculex Pharmaceuticals, Inc. Biocompatible ocular implants
CA2140053C (en) 1994-02-09 2000-04-04 Joel S. Rosenblatt Collagen-based injectable drug delivery system and its use
US5985328A (en) 1994-03-07 1999-11-16 Regents Of The University Of California Micromachined porous membranes with bulk support
US5770076A (en) 1994-03-07 1998-06-23 The Regents Of The University Of California Micromachined capsules having porous membranes and bulk supports
US5516522A (en) 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
US5466233A (en) 1994-04-25 1995-11-14 Escalon Ophthalmics, Inc. Tack for intraocular drug delivery and method for inserting and removing same
AUPM897594A0 (en) 1994-10-25 1994-11-17 Daratech Pty Ltd Controlled release container
EP0788351B1 (en) 1994-11-10 2003-02-05 The University of Kentucky Research Foundation Implantable refillable controlled release device to deliver drugs directly to an internal portion of the body
US5725493A (en) 1994-12-12 1998-03-10 Avery; Robert Logan Intravitreal medicine delivery
US5554132A (en) 1995-03-30 1996-09-10 Abbott Laboratories Hand grip for use with syringe
WO1996036377A1 (en) 1995-05-14 1996-11-21 Optonol Ltd. Intraocular implant, delivery device, and method of implantation
IL113723A (en) 1995-05-14 2002-11-10 Optonol Ltd Intraocular implant
US5609629A (en) 1995-06-07 1997-03-11 Med Institute, Inc. Coated implantable medical device
US6685940B2 (en) 1995-07-27 2004-02-03 Genentech, Inc. Protein formulation
US5773019A (en) 1995-09-27 1998-06-30 The University Of Kentucky Research Foundation Implantable controlled release device to deliver drugs directly to an internal portion of the body
US6641708B1 (en) 1996-01-31 2003-11-04 Board Of Regents, The University Of Texas System Method and apparatus for fractionation using conventional dielectrophoresis and field flow fractionation
GB2310149A (en) 1996-02-15 1997-08-20 Nomix Chipman Ltd Spray gun
US20090005864A1 (en) 1996-03-18 2009-01-01 Eggleston Harry C Modular intraocular implant
US5951512A (en) 1996-05-28 1999-09-14 Horizon Medical Products, Inc. Infusion port with modified drug reservoir
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5928662A (en) 1996-07-31 1999-07-27 Phillips; Andrew F. Ocular drug delivery device
AU7533696A (en) 1996-12-13 1998-06-18 Ciba-Geigy Ag New materials
IL159636A0 (en) 1997-03-31 2004-06-01 Alza Corp Method for preparing a sustained release delivery system
US7160687B1 (en) 1997-05-29 2007-01-09 Cellomics, Inc. Miniaturized cell array methods and apparatus for cell-based screening
US5902598A (en) 1997-08-28 1999-05-11 Control Delivery Systems, Inc. Sustained release drug delivery devices
US6039712A (en) 1997-11-04 2000-03-21 Terence M. Fogarty Implantable injection port
US8313454B2 (en) * 1997-11-20 2012-11-20 Optonol Ltd. Fluid drainage device, delivery device, and associated methods of use and manufacture
KR100246044B1 (ko) * 1998-02-20 2000-03-15 성재갑 투여장치
US6196993B1 (en) 1998-04-20 2001-03-06 Eyelab Group, Llc Ophthalmic insert and method for sustained release of medication to the eye
FR2784296B1 (fr) 1998-09-18 2001-01-05 Imedex Biomateriaux Dispositif pour la formulation et la delivrance d'un melange, notamment pour l'application chirurgicale de ce melange
US7973068B2 (en) 1998-10-20 2011-07-05 Omeros Corporation Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
DE19948783C2 (de) 1999-02-18 2001-06-13 Alcove Surfaces Gmbh Implantat
US7914442B1 (en) 1999-03-01 2011-03-29 Gazdzinski Robert F Endoscopic smart probe and method
US6395300B1 (en) 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6472162B1 (en) 1999-06-04 2002-10-29 Thermogenesis Corp. Method for preparing thrombin for use in a biological glue
PT1187617E (pt) 1999-06-18 2004-06-30 Alcon Mfg Ltd Metodo para seleccionar a concentracao de um farmaco antipatico anti-histaminico pela determinacao da taxa de actividade superficial do farmaco
US6638263B1 (en) 1999-10-12 2003-10-28 Durect Corporation Regulation of drug delivery through flow diversion
TR200201047T2 (tr) 1999-10-21 2002-07-22 Alcon, Inc. İlaç verme vasıtası.
US6416777B1 (en) 1999-10-21 2002-07-09 Alcon Universal Ltd. Ophthalmic drug delivery device
US6331313B1 (en) 1999-10-22 2001-12-18 Oculex Pharmaceticals, Inc. Controlled-release biocompatible ocular drug delivery implant devices and methods
US20030212383A1 (en) 2001-01-05 2003-11-13 Dana Cote System and methods for reducing intraocular pressure
US20050119737A1 (en) 2000-01-12 2005-06-02 Bene Eric A. Ocular implant and methods for making and using same
PL362931A1 (en) 2000-01-12 2004-11-02 Becton, Dickinson And Company Systems and methods for reducing intraocular pressure
US7077848B1 (en) 2000-03-11 2006-07-18 John Hopkins University Sutureless occular surgical methods and instruments for use in such methods
US7169444B2 (en) 2000-03-13 2007-01-30 Seiko Epson Corporation Method for treating surface of ink jet recording medium having recorded image
US7141152B2 (en) 2000-03-16 2006-11-28 Le Febre David A Analyte species separation system
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US6478800B1 (en) * 2000-05-08 2002-11-12 Depuy Acromed, Inc. Medical installation tool
US8251946B2 (en) * 2000-08-24 2012-08-28 Cardiac Science, Inc. Method for constructing an instrument with a two-part plunger for subcutaneous implantation
ATE547080T1 (de) 2000-08-30 2012-03-15 Univ Johns Hopkins Vorrichtungen zur intraokularen arzneimittelabgabe
CA2419681A1 (en) 2000-09-06 2002-03-14 Alcon, Inc. Switchable tackiness coating compositions for ophthalmic implants
US6303290B1 (en) 2000-09-13 2001-10-16 The Trustees Of The University Of Pennsylvania Encapsulation of biomaterials in porous glass-like matrices prepared via an aqueous colloidal sol-gel process
US6756049B2 (en) 2000-12-29 2004-06-29 Bausch & Lomb Incorporated Sustained release drug delivery devices
US6756058B2 (en) 2001-01-03 2004-06-29 Bausch & Lomb Incorporated Sustained release drug delivery devices with multiple agents
JP2004522730A (ja) 2001-01-03 2004-07-29 ボシュ・アンド・ロム・インコーポレイテッド コーティングされた薬剤コアを備えた徐放薬剤送達装置
US6964781B2 (en) 2001-01-03 2005-11-15 Bausch & Lomb Incorporated Sustained release drug delivery devices with prefabricated permeable plugs
AU2002241834B2 (en) 2001-01-09 2006-11-09 Microchips, Inc. Flexible microchip devices for opthalmic and other applications
CA2433528A1 (en) 2001-01-26 2002-08-01 Bausch & Lomb Incorporated Improved process for the production of sustained release drug delivery devices
US7181287B2 (en) 2001-02-13 2007-02-20 Second Sight Medical Products, Inc. Implantable drug delivery device
US6713081B2 (en) 2001-03-15 2004-03-30 The United States Of America As Represented By The Department Of Health And Human Services Ocular therapeutic agent delivery devices and methods for making and using such devices
CA2540761A1 (en) * 2001-03-16 2002-09-26 Glaukos Corporation Applicator and methods for placing a trabecular shunt for glaucoma treatment
US7883717B2 (en) 2001-06-12 2011-02-08 Johns Hopkins University Reservoir device for intraocular drug delivery
WO2003005951A2 (en) 2001-07-10 2003-01-23 Teva Pharmaceutical Industries Ltd. Drug delivery system for zero order, zero order-biphasic, ascending or descending drug delivery
IL144446A0 (en) 2001-07-19 2002-05-23 Prochon Biotech Ltd Plasma protein matrices and methods for their preparation
ATE339170T1 (de) 2001-07-23 2006-10-15 Alcon Inc Vorrichtung zur freisetzung eines ophthalmischen arzneimittels
WO2003009774A2 (en) 2001-07-23 2003-02-06 Alcon, Inc. Ophthalmic drug delivery device
BR0205990A (pt) 2001-08-29 2004-01-13 Ricardo Azevedo Ponte Carvalho Um sistema implantável de liberação unidirecional de agentes terapêuticos para tecidos
US7749528B2 (en) 2001-08-29 2010-07-06 Ricardo Azevedo Pontes De Carvalho Implantable and sealable medical device for unidirectional delivery of therapeutic agents to tissues
AU2002341959A1 (en) 2001-10-04 2003-04-14 Case Western Reserve University Drug delivery devices and methods
US8663687B2 (en) 2001-10-12 2014-03-04 Monosol Rx, Llc Film compositions for delivery of actives
AU2002352746A1 (en) 2001-11-15 2003-06-10 Arryx, Inc. Sample chip
US7090888B2 (en) 2002-01-18 2006-08-15 Snyder Michael E Sustained release ophthalmological device and method of making and using the same
US8364229B2 (en) 2003-07-25 2013-01-29 Dexcom, Inc. Analyte sensors having a signal-to-noise ratio substantially unaffected by non-constant noise
KR101191254B1 (ko) 2002-03-11 2012-10-16 알콘, 인코퍼레이티드 이식 가능한 약물 전달 시스템
US7074426B2 (en) 2002-03-27 2006-07-11 Frank Kochinke Methods and drug delivery systems for the treatment of orofacial diseases
US7939094B2 (en) 2002-06-19 2011-05-10 Boston Scientific Scimed, Inc. Multiphase polymeric drug release region
WO2004006889A1 (en) 2002-07-15 2004-01-22 Alcon, Inc. Bioerodible film for ophthalmic drug delivery
US8425549B2 (en) 2002-07-23 2013-04-23 Reverse Medical Corporation Systems and methods for removing obstructive matter from body lumens and treating vascular defects
US20040019325A1 (en) 2002-07-29 2004-01-29 Medrip Ltd. Syringe Pump
CA2495621C (en) * 2002-09-18 2008-02-12 Allergan, Inc. Methods and apparatus for delivery of ocular implants
US7468065B2 (en) 2002-09-18 2008-12-23 Allergan, Inc. Apparatus for delivery of ocular implants
CA2689424A1 (en) 2002-09-29 2004-04-08 Surmodics, Inc. Methods for treatment and/or prevention of retinal disease
WO2004066871A2 (en) 2003-01-24 2004-08-12 Doheny Retina Institute Reservoirs with subretinal cannula for subretinal drug delivery
US20060167435A1 (en) 2003-02-18 2006-07-27 Adamis Anthony P Transscleral drug delivery device and related methods
WO2004076647A2 (en) 2003-02-26 2004-09-10 The Regents Of The University Of California Use of steady-state oxygen gradients to modulate animal cell functions
US20050255144A1 (en) 2003-04-09 2005-11-17 Directcontact Llc Methods and articles for the delivery of medicaments to the eye for the treatment of posterior segment diseases
US20050074497A1 (en) 2003-04-09 2005-04-07 Schultz Clyde L. Hydrogels used to deliver medicaments to the eye for the treatment of posterior segment diseases
JP4824549B2 (ja) 2003-05-02 2011-11-30 サーモディクス，インコーポレイティド 制御放出型の生体活性物質デリバリー・デバイス
EP1671624B1 (en) 2003-05-02 2010-08-11 SurModics, Inc. Delivery device for a controlled drug release of an active agent into the posterior section of the eye
US8403941B2 (en) * 2003-06-02 2013-03-26 Abbott Medical Optics Inc. Intraocular lens and cartridge packaging with lens-loading function
CA2529048A1 (en) 2003-06-13 2005-02-24 Becton, Dickinson And Company Improved intra-dermal delivery of biologically active agents
US20040260381A1 (en) 2003-06-18 2004-12-23 D-Crown Ltd Devices and methods for forming stenting structures in situ
WO2004112653A2 (en) 2003-06-18 2004-12-29 D-Crown Ltd. Devices and methods for delivering and forming single and multiple stenting structures in situ
US20040260380A1 (en) 2003-06-18 2004-12-23 D-Crown Ltd Devices for delivering multiple stenting structures in situ
US8367410B2 (en) 2003-06-20 2013-02-05 Massachusetts Institute Of Technology Application of electrical stimulation for functional tissue engineering in vitro and in vivo
JP2007526019A (ja) 2003-07-10 2007-09-13 アルコン，インコーポレイティド 眼科用薬物送達デバイス
FI120333B (fi) 2003-08-20 2009-09-30 Bioretec Oy Huokoinen lääketieteellinen väline ja menetelmä sen valmistamiseksi
US7252673B2 (en) * 2003-09-10 2007-08-07 Warsaw Orthopedic, Inc. Devices and methods for inserting spinal implants
CA2539324A1 (en) 2003-09-18 2005-03-31 Macusight, Inc. Transscleral delivery
US20050181018A1 (en) 2003-09-19 2005-08-18 Peyman Gholam A. Ocular drug delivery
AU2006225241B2 (en) 2003-09-24 2008-07-17 Tianda Pharmaceuticals (Australia) Pty Limited Medication Holder
NZ546730A (en) 2003-09-24 2008-04-30 Medi Stream Pty Ltd Medication holder
US7615141B2 (en) 2003-10-03 2009-11-10 University Of Washington Electrochemical micromanufacturing system and method
US7211272B2 (en) 2003-12-22 2007-05-01 Bausch & Lomb Incorporated Drug delivery device
JP4602356B2 (ja) 2004-02-12 2010-12-22 ネオビスタ、インコーポレイテッド 眼内近接照射療法のための方法および装置
US7276050B2 (en) 2004-03-02 2007-10-02 Alan Franklin Trans-scleral drug delivery method and apparatus
WO2005091922A2 (en) 2004-03-03 2005-10-06 Becton, Dickinson And Company Methods and devices for improving delivery of a substance to skin
CA2562542A1 (en) * 2004-04-22 2005-11-03 Advanced Vision Science, Inc. Device for inserting deformable intraocular lenses
US8685435B2 (en) 2004-04-30 2014-04-01 Allergan, Inc. Extended release biodegradable ocular implants
US20060182783A1 (en) 2004-04-30 2006-08-17 Allergan, Inc. Sustained release intraocular drug delivery systems
US20070059336A1 (en) 2004-04-30 2007-03-15 Allergan, Inc. Anti-angiogenic sustained release intraocular implants and related methods
US8591885B2 (en) 2004-04-30 2013-11-26 Allergan, Inc. Carbonic anhydrase inhibitor sustained release intraocular drug delivery systems
US20050244469A1 (en) 2004-04-30 2005-11-03 Allergan, Inc. Extended therapeutic effect ocular implant treatments
WO2005110374A1 (en) 2004-04-30 2005-11-24 Allergan, Inc. Intraocular drug delivery systems containing a therapeutic component, a cyclodextrin, and a polymeric component
US20060110428A1 (en) 2004-07-02 2006-05-25 Eugene Dejuan Methods and devices for the treatment of ocular conditions
US7117870B2 (en) 2004-07-26 2006-10-10 Clarity Corporation Lacrimal insert having reservoir with controlled release of medication and method of manufacturing the same
AU2005267734A1 (en) 2004-08-06 2006-02-09 Sopherion Therapeutics, Inc. Anti-angiogenic peptides and methods of use thereof
WO2006031358A2 (en) 2004-08-13 2006-03-23 Hyperbranch Medical Technology, Inc. Dendritic polymers, crosslinked gels, and their uses as ophthalmic sealants and lenses
US20060104969A1 (en) 2004-08-16 2006-05-18 Massachusetts Institute Of Technology Compositions and methods for enhancing structural and functional nervous system reorganization and recovery
WO2006031388A2 (en) 2004-08-20 2006-03-23 Hyperbranch Medical Technology, Inc. Dentritic polymers, crosslinked gels, and their uses in orthopedic applications
US20060052754A1 (en) 2004-09-04 2006-03-09 Fields Douglas W Thumb trigger syringe pole
US7709049B2 (en) 2004-09-10 2010-05-04 Surmodics, Inc. Methods, devices, and coatings for controlled active agent release
NZ554426A (en) 2004-10-01 2010-05-28 Ramscor Inc Conveniently implantable sustained release drug compositions comprising at least one non-polymeric excipient
US20080038316A1 (en) 2004-10-01 2008-02-14 Wong Vernon G Conveniently implantable sustained release drug compositions
CA2583399A1 (en) 2004-10-14 2006-04-27 Sopherion Therapeutics, Inc. Anti-angiogenic peptides and methods of use thereof
JO3000B1 (ar) 2004-10-20 2016-09-05 Genentech Inc مركبات أجسام مضادة .
US20060129215A1 (en) 2004-12-09 2006-06-15 Helmus Michael N Medical devices having nanostructured regions for controlled tissue biocompatibility and drug delivery
US20060154981A1 (en) 2005-01-12 2006-07-13 Alcon, Inc. Method of reducing intraocular pressure and treating glaucoma
WO2006082588A2 (en) 2005-02-07 2006-08-10 Pharmalight Inc. Method and device for ophthalmic administration of active pharmaceutical ingredients
US20060233858A1 (en) 2005-03-08 2006-10-19 Allergan, Inc. Systems and methods providing targeted intraocular drug delivery
WO2006102378A2 (en) 2005-03-21 2006-09-28 Macusight, Inc. Drug delivery systems for treatment of diseases or conditions
US20070077270A1 (en) 2005-03-28 2007-04-05 Clemson University Delivery devices and methods for long-term, targeted delivery of therapeutic agents to the eye and ear
JP4937997B2 (ja) 2005-03-30 2012-05-23 ニューレンズ・リミテッド 調節型眼内レンズ（ａｉｏｌ）アセンブリおよびそのための個別の構成要素
US20070066138A1 (en) 2005-04-05 2007-03-22 The Ohio State University Research Foundation Diffusion Delivery Systems and Methods of Fabrication
US20100168535A1 (en) 2006-04-12 2010-07-01 Mark Ries Robinson Methods and apparatuses related to blood analyte measurement system
US20060258994A1 (en) 2005-05-12 2006-11-16 Avery Robert L Implantable delivery device for administering pharmacological agents to an internal portion of a body
CA2608366A1 (en) 2005-05-18 2006-11-23 Surmodics, Inc. Insertion instrument for non-linear medical devices
WO2006127962A2 (en) 2005-05-25 2006-11-30 Becton, Dickinson And Comapny Particulate formulations for intradermal delivery of biologically active agents
US20060276738A1 (en) 2005-06-06 2006-12-07 Becker Bruce B Lacrimal drainage bypass device and method
KR20080043763A (ko) 2005-06-17 2008-05-19 다이나미스 테라퓨틱스, 인코포레이티드 염증성 상태의 치료
US7893040B2 (en) 2005-07-22 2011-02-22 Oculis Ehf Cyclodextrin nanotechnology for ophthalmic drug delivery
US8663673B2 (en) 2005-07-29 2014-03-04 Surmodics, Inc. Devices, articles, coatings, and methods for controlled active agent release or hemocompatibility
US20070060887A1 (en) * 2005-08-22 2007-03-15 Marsh David A Ophthalmic injector
US20070212397A1 (en) 2005-09-15 2007-09-13 Roth Daniel B Pharmaceutical delivery device and method for providing ocular treatment
WO2007035621A1 (en) 2005-09-16 2007-03-29 (Osi) Eyetech, Inc. Ophthalmic syringe
US20080003219A1 (en) 2005-09-26 2008-01-03 Minu, L.L.C. Delivery of an ocular agent
US20080167600A1 (en) 2005-09-26 2008-07-10 Peyman Gholam A Device for delivery of an agent to the eye and other sites
US20070072933A1 (en) 2005-09-26 2007-03-29 Peyman Gholam A Delivery of an ocular agent
WO2007038453A2 (en) 2005-09-26 2007-04-05 Advanced Ocular Systems Limited Use of an anti-vascular endothelial growth factor (vegf) agent to ameliorate inflammation
US20070071756A1 (en) 2005-09-26 2007-03-29 Peyman Gholam A Delivery of an agent to ameliorate inflammation
TW200732347A (en) 2005-10-06 2007-09-01 Trophogen Inc VEGF analogs and methods of use
US8168584B2 (en) 2005-10-08 2012-05-01 Potentia Pharmaceuticals, Inc. Methods of treating age-related macular degeneration by compstatin and analogs thereof
US20090043253A1 (en) 2005-10-11 2009-02-12 Blake Podaima Smart medical compliance method and system
US20080125406A1 (en) 2005-10-14 2008-05-29 Robin Alan L Method for Treating Primary and Secondary Forms of Glaucoma
RU2008118889A (ru) 2005-10-14 2009-11-20 Алькон, Инк. (Ch) Спососб лечения первичных и вторичных форм глаукомы
JP4721425B2 (ja) 2005-12-01 2011-07-13 キヤノン株式会社 流体移動方法および流体移動装置
JP5283509B2 (ja) 2005-12-07 2013-09-04 ラモット・アット・テル・アビブ・ユニバーシテイ・リミテッド 薬物送達複合構造体
US20070131611A1 (en) 2005-12-13 2007-06-14 General Electric Company Membrane-based article and associated method
US20070131610A1 (en) 2005-12-13 2007-06-14 General Electric Company Membrane-based apparatus and associated method
PT2526910E (pt) 2006-01-17 2015-11-18 Transcend Medical Inc Dispositivo para tratamento de glaucoma
ES2653845T3 (es) 2006-01-17 2018-02-09 Novartis Ag Dispositivo de tratamiento de administración de fármaco
US20080216736A1 (en) 2006-01-19 2008-09-11 Takeda San Diego, Inc. Microfluidic device with diffusion between adjacent lumens
WO2007100986A2 (en) 2006-02-24 2007-09-07 Rosetta Inpharmatics Llc Extraction and diagnostic fluid devices, systems and methods of use
WO2007101204A1 (en) 2006-02-27 2007-09-07 Alcon Research, Ltd. Method of treating glaucoma
CA2648421C (en) 2006-03-31 2016-01-12 Qlt Plug Delivery, Inc. Nasolacrimal drainage system implants for drug therapy
WO2007117394A2 (en) 2006-03-31 2007-10-18 Dynamis Therapeutics, Inc. Compositions and methods related to fructosamine-3-kinase inhibitors
EP2014322A4 (en) 2006-04-18 2012-09-26 Zhongshan Botai Pharmaceutic Instr Co Ltd STERILIZED SYRINGE FOR MIXING MEDICINES
US8197435B2 (en) 2006-05-02 2012-06-12 Emory University Methods and devices for drug delivery to ocular tissue using microneedle
WO2007131050A2 (en) 2006-05-02 2007-11-15 Georgia Tech Research Corporation Method for drug delivery to ocular tissue using microneedle
US20080124372A1 (en) 2006-06-06 2008-05-29 Hossainy Syed F A Morphology profiles for control of agent release rates from polymer matrices
US8968782B2 (en) 2006-06-28 2015-03-03 Surmodics, Inc. Combination degradable and non-degradable matrices for active agent delivery
TW200815045A (en) 2006-06-29 2008-04-01 Jazz Pharmaceuticals Inc Pharmaceutical compositions of ropinirole and methods of use thereof
US20080108933A1 (en) 2006-06-30 2008-05-08 Dao-Yi Yu Methods, Systems and Apparatus for Relieving Pressure in an Organ
CA2657064C (en) 2006-07-19 2014-09-23 Noab Biodiscoveries Inc. Method and device to extract components contained in a fluid
EP2046437A2 (en) 2006-07-20 2009-04-15 Neurosystec Corporation Devices, systems and methods for ophthalmic drug delivery
WO2008016712A2 (en) 2006-08-02 2008-02-07 Inframat Corporation Medical devices and methods of making and using
US20080097335A1 (en) * 2006-08-04 2008-04-24 Allergan, Inc. Ocular implant delivery assemblies
JP2008054521A (ja) 2006-08-29 2008-03-13 Canon Inc 細胞培養処理装置及び細胞培養処理方法
WO2008033924A2 (en) 2006-09-12 2008-03-20 Board Of Regents Of The University Of Nebraska Methods and compositions for targeted delivery of therapeutic agents
US20080066739A1 (en) 2006-09-20 2008-03-20 Lemahieu Edward Methods and systems of delivering medication via inhalation
JP5694664B2 (ja) 2006-09-29 2015-04-01 サーモディクス，インコーポレイティド 生分解性眼用インプラント及び眼の病気を治療する方法
WO2008045272A2 (en) 2006-10-06 2008-04-17 Dynamis Therapeutics, Inc. Compositions and methods for skin lightening
US9022970B2 (en) 2006-10-16 2015-05-05 Alcon Research, Ltd. Ophthalmic injection device including dosage control device
US8784898B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of wound care and treatment
WO2008052145A2 (en) 2006-10-25 2008-05-02 Revalesio Corporation Methods of therapeutic treatment of eyes and other human tissues using an oxygen-enriched solution
US8784897B2 (en) 2006-10-25 2014-07-22 Revalesio Corporation Methods of therapeutic treatment of eyes
JP5491185B2 (ja) 2006-10-25 2014-05-14 リバルシオ コーポレイション 傷のケアおよび処置の方法
US8609148B2 (en) 2006-10-25 2013-12-17 Revalesio Corporation Methods of therapeutic treatment of eyes
EP2088976B1 (en) 2006-11-10 2019-07-03 Glaukos Corporation Uveoscleral shunt
US20080111282A1 (en) 2006-11-10 2008-05-15 Baojun Xie Process for Making Three Dimensional Objects From Dispersions of Polymer Colloidal Particles
US20100286791A1 (en) 2006-11-21 2010-11-11 Goldsmith David S Integrated system for the ballistic and nonballistic infixion and retrieval of implants
US20090263346A1 (en) 2006-12-05 2009-10-22 David Taft Systems and methods for delivery of drugs
US8956602B2 (en) 2006-12-05 2015-02-17 Landec, Inc. Delivery of drugs
US20080154241A1 (en) 2006-12-07 2008-06-26 Burkstrand Michael J Latent stabilization of bioactive agents releasable from implantable medical articles
US20080147021A1 (en) 2006-12-15 2008-06-19 Jani Dharmendra M Drug delivery devices
JP5323720B2 (ja) 2006-12-18 2013-10-23 アルコン リサーチ， リミテッド 眼用薬物送達のためのデバイスおよび方法
CA2674076A1 (en) 2006-12-26 2008-07-10 Qlt Plug Delivery, Inc. Drug delivery implants for inhibition of optical defects
CA2674877C (en) * 2007-01-09 2016-03-15 Fovea Pharmaceuticals Apparatus for intra-ocular injection
EP2104473A1 (en) 2007-01-19 2009-09-30 Cinvention Ag Porous, non-degradable implant made by powder molding
UY30883A1 (es) 2007-01-31 2008-05-31 Alcon Res Tapones punctales y metodos de liberacion de agentes terapeuticos
US7905888B2 (en) 2007-02-16 2011-03-15 Brown David C Apparatus for inserting flexible medical implant
WO2008116165A2 (en) 2007-03-21 2008-09-25 Next Safety, Inc. Methods and systems of delivering medication via inhalation
US20080249501A1 (en) 2007-04-09 2008-10-09 Medtronic Vascular, Inc. Methods for Simultaneous Injection and Aspiration of Fluids During a Medical Procedure
US20080286338A1 (en) 2007-05-15 2008-11-20 Boston Foundation For Sight Drug delivery system with scleral lens
US8231892B2 (en) 2007-05-24 2012-07-31 Allergan, Inc. Biodegradable drug delivery system
US9365634B2 (en) 2007-05-29 2016-06-14 Angiochem Inc. Aprotinin-like polypeptides for delivering agents conjugated thereto to tissues
PL2164866T3 (pl) 2007-05-29 2014-10-31 Angiochem Inc Polipeptydy podobne do aprotyniny do dostarczania skoniugowanych z nimi środków do tkanek
US20090036827A1 (en) 2007-07-31 2009-02-05 Karl Cazzini Juxtascleral Drug Delivery and Ocular Implant System
WO2009023615A1 (en) 2007-08-10 2009-02-19 Trustees Of Tufts College Tubular silk compositions and methods of use thereof
MX2010002618A (es) 2007-09-07 2010-11-10 Qlt Plug Delivery Inc Herramientas de insercion y extraccion para implantes lagrimales.
CA2698580C (en) 2007-09-07 2016-10-11 Qlt Plug Delivery, Inc. Lacrimal implant detection
KR101696301B1 (ko) 2007-09-07 2017-01-13 마티 테라퓨틱스 인코포레이티드 치료 약제의 서방성 약물 코어
US8308755B2 (en) 2007-09-24 2012-11-13 Ethicon Endo-Surgery, Inc. Elliptical retractor
US20090214601A1 (en) 2007-09-28 2009-08-27 Chappa Ralph A Porous Drug Delivery Devices and Related Methods
RU2475282C2 (ru) 2007-10-05 2013-02-20 Тико Хелскеа Груп Лп Герметизирующий фиксатор для использования при хирургических операциях
US20100004189A1 (en) 2007-10-25 2010-01-07 Revalesio Corporation Compositions and methods for treating cystic fibrosis
US9523090B2 (en) 2007-10-25 2016-12-20 Revalesio Corporation Compositions and methods for treating inflammation
WO2009055620A1 (en) 2007-10-25 2009-04-30 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US20090227018A1 (en) 2007-10-25 2009-09-10 Revalesio Corporation Compositions and methods for modulating cellular membrane-mediated intracellular signal transduction
WO2010062628A1 (en) 2008-10-27 2010-06-03 Revalesio Corporation Compositions and methods for treating asthma and other lung disorders
US20100008997A1 (en) 2007-10-25 2010-01-14 Revalesio Corporation Compositions and methods for treating asthma and other lung disorders
US10125359B2 (en) 2007-10-25 2018-11-13 Revalesio Corporation Compositions and methods for treating inflammation
US20100303917A1 (en) 2007-10-25 2010-12-02 Revalesio Corporation Compositions and methods for treating cystic fibrosis
US20090263495A1 (en) 2007-10-25 2009-10-22 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US20100303918A1 (en) 2007-10-25 2010-12-02 Revalesio Corporation Compositions and methods for treating asthma and other lung disorders
US20100009008A1 (en) 2007-10-25 2010-01-14 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
US20100310665A1 (en) 2007-10-25 2010-12-09 Revalesio Corporation Bacteriostatic or bacteriocidal compositions and methods
EP2214644B1 (en) 2007-11-05 2013-03-20 Bausch & Lomb Incorporated Water-immiscible materials as vehicles for drug delivery
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
ES2425769T5 (es) 2007-12-20 2017-07-28 University Of Southern California Aparato para la administración de agentes terapéuticos
US8414646B2 (en) 2007-12-27 2013-04-09 Forsight Labs, Llc Intraocular, accommodating lens and methods of use
WO2009089409A2 (en) 2008-01-10 2009-07-16 Bausch & Lomb Incorporated Intravitreal injection system having coaxial cannulae and use thereof
WO2009094466A2 (en) 2008-01-22 2009-07-30 University Of Florida Research Foundation, Inc. Contact lenses for extended release of bioactive agents containing diffusion attenuators
US8201752B2 (en) 2008-03-10 2012-06-19 Vapore, Inc. Low energy vaporization of liquids: apparatus and methods
TNSN08110A1 (en) 2008-03-11 2009-07-14 Rekik Raouf Dr Drug delivery to the anterior and posterior segment of the eye from drops
EP2257326A2 (en) 2008-03-21 2010-12-08 Novartis AG Powder dispersion apparatus
KR101674492B1 (ko) 2008-03-31 2016-11-09 닛토덴코 가부시키가이샤 침투제 전달 시스템 및 그의 사용방법
ES2452935T3 (es) 2008-04-04 2014-04-03 Nektar Therapeutics Dispositivo de aerosolización
EP2276508A4 (en) 2008-04-15 2011-12-28 Sarcode Bioscience Inc ADMINISTRATION OF LFA-1 ANTAGONISTS TO THE GASTROINTESTINAL SYSTEM
US8636795B2 (en) 2008-04-25 2014-01-28 The Regents Of The University Of California Device to store and inject corneal graft
CN102105137B (zh) 2008-04-30 2015-01-07 Qlt股份有限公司 复合泪管植入物及相关方法
WO2009134929A2 (en) 2008-05-01 2009-11-05 Revalesio Corporation Compositions and methods for treating digestive disorders
US7846124B2 (en) 2008-05-07 2010-12-07 Becker Bruce B Punctal anchor for lacrimal stent, introducer tool and method
MX2010012212A (es) 2008-05-08 2011-09-27 Minipumps Llc Dispositivos implantables para suministro de fármacos, y áparato y métodos para llenar los dispositivos.
CA2769307C (en) 2008-07-11 2017-12-12 Intellicyt Corporation Multi-sample particle analyzer system and method for high throughput screening
CA2731435A1 (en) 2008-07-21 2010-01-28 Arstasis, Inc. Devices, methods, and kits for forming tracts in tissue
US20100022943A1 (en) 2008-07-25 2010-01-28 Medtronic Vascular, Inc. Hydrodynamic Thrombectomy Catheter
US20100023033A1 (en) 2008-07-25 2010-01-28 Medtronic Vescular, Inc. Hydrodynamic Thrombectomy Catheter
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
US8221353B2 (en) 2008-10-21 2012-07-17 KMG Pharma, Inc Intravitreal injection device and system
US7678078B1 (en) 2008-10-21 2010-03-16 KMG Pharma LLC Intravitreal injection device, system and method
DE102008054431B3 (de) 2008-12-09 2010-06-17 Pari Pharma Gmbh Aerosoltherapievorrichtung
MX2011006726A (es) 2009-01-02 2011-07-20 Alcon Res Ltd Implante oftalmico recargable in situ.
US8235932B2 (en) 2009-01-09 2012-08-07 Becker Bruce B Side-by-side lacrimal intubation threader and method
US8545554B2 (en) 2009-01-16 2013-10-01 Allergan, Inc. Intraocular injector
US8623395B2 (en) 2010-01-29 2014-01-07 Forsight Vision4, Inc. Implantable therapeutic device
SG2014007389A (en) 2009-01-29 2014-04-28 Forsight Vision4 Inc Posterior segment drug delivery
WO2010093945A2 (en) 2009-02-13 2010-08-19 Glaukos Corporation Uveoscleral drug delivery implant and methods for implanting the same
HUE059078T2 (hu) 2009-02-20 2022-10-28 Enhanx Biopharm Inc Glutation-alapú hatóanyagszállító rendszer
US8287494B2 (en) 2009-03-23 2012-10-16 Colin Ma Intravitreal injection devices and methods of injecting a substance into the vitreous chamber of the eye
EP2424507A4 (en) 2009-04-27 2012-10-24 Revalesio Corp COMPOSITIONS AND METHODS FOR THE TREATMENT OF INSULIN AND DIABETES RESISTANCE
WO2010125416A1 (en) 2009-04-27 2010-11-04 Raouf Rekik Drug delivery to the anterior and posterior segments of the eye
US8815292B2 (en) 2009-04-27 2014-08-26 Revalesio Corporation Compositions and methods for treating insulin resistance and diabetes mellitus
CN102802541A (zh) 2009-05-15 2012-11-28 阿尔斯塔西斯公司 在组织中形成管道的装置、方法和成套用具
EP3785683B1 (en) 2009-05-18 2023-11-01 Dose Medical Corporation Drug eluting ocular implant
EP4108216A1 (en) 2009-06-03 2022-12-28 Forsight Vision5, Inc. Anterior segment drug delivery
US9005649B2 (en) 2009-07-14 2015-04-14 Board Of Regents, The University Of Texas System Methods for making controlled delivery devices having zero order kinetics
WO2011008986A2 (en) 2009-07-15 2011-01-20 California Institute Of Technology A method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves
BR112012003077A2 (pt) 2009-08-14 2019-09-24 Genentech Inc mercadorias biologicas para monitorar resposta em paciente para antagonistas de vegf
WO2011028850A1 (en) 2009-09-01 2011-03-10 Northwestern University Delivery of therapeutic agents using oligonucleotide-modified nanoparticles as carriers
WO2011034627A2 (en) 2009-09-21 2011-03-24 Harvard Bioscience, Inc. Methods and apparatus for introducing cells at a tissue site
EP2512389B1 (en) * 2009-12-16 2015-09-02 Allergan, Inc. Intracameral devices for sustained delivery
CA2785468A1 (en) 2009-12-23 2011-06-30 Psivida Us, Inc. Sustained release delivery devices
US8430853B2 (en) 2010-02-05 2013-04-30 Johnson & Johnson Vision Care, Inc. Implantation instruments, system, and kit for punctal implants
JP5511530B2 (ja) * 2010-06-10 2014-06-04 Ｈｏｙａ株式会社 眼内レンズ挿入装置
PL2600930T3 (pl) 2010-08-05 2021-09-06 Forsight Vision4, Inc. Urządzenie wstrzykujące do dostarczania leku
PL2600812T3 (pl) 2010-08-05 2022-01-24 Forsight Vision4, Inc. Urządzenie do leczenia oczu
AU2011285548B2 (en) 2010-08-05 2014-02-06 Forsight Vision4, Inc. Combined drug delivery methods and apparatus
CA2807508A1 (en) 2010-08-05 2012-02-09 Forsight Vision4, Inc. Subconjunctival implant for posterior segment drug delivery
US20140033800A1 (en) 2010-11-11 2014-02-06 Forsight Vision4, Inc. Methods and apparatus to determine diffusion properties of porous structures for drug delivery
US20140031769A1 (en) 2010-11-19 2014-01-30 Forsight Vision4, Inc. Therapeutic agent formulations for implanted devices
EP4249059B1 (en) 2011-06-28 2025-07-30 ForSight Vision4, Inc. An apparatus for collecting a sample of fluid from a reservoir chamber of a therapeutic device for the eye
EP2739252A4 (en) 2011-08-05 2015-08-12 Forsight Vision4 Inc DISPOSAL OF SMALL MOLECULES THROUGH AN IMPLANTABLE THERAPEUTIC DEVICE
SI2755600T1 (sl) 2011-09-16 2021-08-31 Forsight Vision4, Inc. Naprava za izmenjavo tekočine
FR2980102B1 (fr) * 2011-09-16 2014-10-31 Medicontur Orvostechnikai Korlatolt Felelossegu Tarsasag Dispositif pour injecter une lentille intraoculaire dans un œil
US20140326249A1 (en) 2011-12-02 2014-11-06 Bioceptive, Inc. Methods and apparatus for inserting a device or pharmaceutical into a uterus
WO2013116061A1 (en) 2012-02-03 2013-08-08 Forsight Vision4, Inc. Insertion and removal methods and apparatus for therapeutic devices
KR102125004B1 (ko) * 2012-06-04 2020-06-22 알콘 인코포레이티드 안구내 수정체 삽입기
AU2014236455B2 (en) 2013-03-14 2018-07-12 Forsight Vision4, Inc. Systems for sustained intraocular delivery of low solubility compounds from a port delivery system implant
US9526654B2 (en) 2013-03-28 2016-12-27 Forsight Vision4, Inc. Ophthalmic implant for delivering therapeutic substances
JP6457485B2 (ja) * 2013-04-03 2019-01-23 ノバルティス アーゲー 自動化された眼内レンズ注入器デバイス
US9987163B2 (en) * 2013-04-16 2018-06-05 Novartis Ag Device for dispensing intraocular substances
US20160302965A1 (en) 2013-12-06 2016-10-20 Forsight Vision4, Inc. Implantable therapeutic devices
CA2955186C (en) 2014-07-15 2023-08-29 Forsight Vision4, Inc. Ocular implant delivery device and method
CA2957548A1 (en) 2014-08-08 2016-02-11 Forsight Vision4, Inc. Stable and soluble formulations of receptor tyrosine kinase inhibitors, and methods of preparation thereof
CN107249515B (zh) 2014-11-10 2019-10-01 弗赛特影像4股份有限公司 可膨胀药物递送装置和使用方法
JP6912475B2 (ja) 2015-11-20 2021-08-04 フォーサイト・ビジョン フォー・インコーポレーテッドＦｏｒｓｉｇｈｔ Ｖｉｓｉｏｎ４， Ｉｎｃ． 持続放出性薬物送達機器用の多孔質構造体
EP3439591B1 (en) 2016-04-05 2020-09-23 ForSight Vision4, Inc. Implantable ocular drug delivery devices

Also Published As

Publication number Publication date
US20220378609A1 (en) 2022-12-01
EP3169289B1 (en) 2020-04-15
WO2016011191A1 (en) 2016-01-21
US20250367028A1 (en) 2025-12-04
KR20170034396A (ko) 2017-03-28
EP3679908B1 (en) 2024-09-04
RU2017104650A3 (es) 2019-02-18
BR112017000774A2 (pt) 2017-11-28
CA2955186A1 (en) 2016-01-21
RU2017104650A (ru) 2018-08-15
EP3679908A1 (en) 2020-07-15
EP3169289A4 (en) 2018-03-07
CA2955186C (en) 2023-08-29
ZA201700387B (en) 2019-12-18
US12343283B2 (en) 2025-07-01
NZ728374A (en) 2021-02-26
RU2695563C2 (ru) 2019-07-24
US11337853B2 (en) 2022-05-24
MX384889B (es) 2025-03-14
MY182497A (en) 2021-01-25
US10258503B2 (en) 2019-04-16
CN106687079B (zh) 2019-10-11
AU2015289625A1 (en) 2017-02-02
ES2803102T3 (es) 2021-01-22
EP3679908C0 (en) 2024-09-04
IL250079B (en) 2021-08-31
JP2017521219A (ja) 2017-08-03
US20190350754A1 (en) 2019-11-21
CN106687079A (zh) 2017-05-17
ES2992100T3 (es) 2024-12-09
KR102416726B1 (ko) 2022-07-05
EP3169289A1 (en) 2017-05-24
BR112017000774B1 (pt) 2021-12-14
JP6581194B2 (ja) 2019-09-25
AU2015289625B2 (en) 2019-10-10
IL250079A0 (en) 2017-03-30
US20170165108A1 (en) 2017-06-15

Similar Documents

Publication Publication Date Title
MX2017000609A (es) Dispositivo y metodo de entrega de implante ocular.
AR103130A1 (es) Sonda de vitrectomía con un escáner de fibra óptica
PE20170167A1 (es) Conjunto de cable de fibra optica para terminacion de un cable de fibra optica y metodos de fabricacion de los mismos
MX393142B (es) Dispositivos y metodos para formar una fistula.
MX2016016069A (es) Dispositivo de administración de agente terapeutico con lumen convergente.
CL2017000416A1 (es) Métodos para tratar el mieloma múltiple con compuestos inmunomoduladores en combinación con anticuerpos
BR112016010205A2 (pt) ?sistema de vacinação para aplicar vacina para frangas e métodos, dispositivos e montagens associadas??
AR096893A1 (es) Composición de un antagonista del factor de crecimiento del endotelio vascular (vegf, por sus siglas en inglés) para tratamiento de retinoterapia del prematuro
MX2017008277A (es) Solucion oftalmica acuosa.
MA40535A (fr) Imagerie et thérapie d'une inflammation et d'une infection ciblant hsp90
GT201700194A (es) Formulación de combinación de tesofensina y betabloqueante
EP3130620A4 (en) Silicone composition, silicone emulsion composition, and fiber treatment agent
CO2017001842A2 (es) Artículo y método para mantener el flujo menstrual dentro de la vagina
ZA201807438B (en) Methods of treating ocular conditions
PH12017500602A1 (en) Methods for treating ocular conditions
MX2016014074A (es) Campo quirurgico con acceso de sistema esteril.
MX381068B (es) Sistemas y métodos para control de sondas.
CL2016002391A1 (es) Ensamble de filtro.
IL258172A (en) Adaptation, process and use for introducing ingredients into the bladder via voiding without a catheter
MX367993B (es) Organizador para cables de fibra y líneas de acometida.
MX2016015342A (es) Cono de aguja para cateter de insercion sobre la aguja.
MX2018008196A (es) Tratamiento para cancer de mama usando una combinacion de una formulacion liposomal cationica de taxano, una formulacion no liposomal de taxano y un agente activo adicional.
MX2017009313A (es) Formulaciones intravenosas de baclofeno y metodos de tratamiento.
CL2015002785A1 (es) Método y sistema para transferir configuraciones de un usuario a otro dispositivo receptor del usuario
ES2721648T3 (es) Cuadro de bicicleta y poste de asiento asociado